KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Labcorp Holdings (LH) EBT (2016 - 2026)

Labcorp Holdings' EBT history spans 18 years, with the latest figure at $319.7 million for Q1 2026.

  • On a quarterly basis, EBT rose 16.17% to $319.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.2 billion, a 22.91% increase, with the full-year FY2025 number at $1.1 billion, up 15.42% from a year prior.
  • EBT hit $319.7 million in Q1 2026 for Labcorp Holdings, up from $190.6 million in the prior quarter.
  • Over the last five years, EBT for LH hit a ceiling of $640.1 million in Q1 2022 and a floor of -$147.1 million in Q4 2023.
  • Historically, EBT has averaged $251.9 million across 5 years, with a median of $272.3 million in 2023.
  • Biggest five-year swings in EBT: tumbled 1542.16% in 2023 and later surged 224.95% in 2024.
  • Tracing LH's EBT over 5 years: stood at $10.2 million in 2022, then plummeted by 1542.16% to -$147.1 million in 2023, then surged by 224.95% to $183.8 million in 2024, then grew by 3.7% to $190.6 million in 2025, then soared by 67.73% to $319.7 million in 2026.
  • Business Quant data shows EBT for LH at $319.7 million in Q1 2026, $190.6 million in Q4 2025, and $337.0 million in Q3 2025.